Cargando…
Effects of metformin on disease flares in patients with systemic lupus erythematosus: post hoc analyses from two randomised trials
OBJECTIVE: To confirm that metformin prevents flares in patients with SLE with low disease activity, we performed a post hoc analysis combining our previous two randomised trials. METHODS: Post hoc analyses were performed on data from the open-labelled proof-of-concept trial (n=113, ChiCTR-TRC-12002...
Autores principales: | Sun, Fangfang, Geng, Shikai, Wang, Haiting, Wang, Huijing, Liu, Zhe, Wang, Xiaodong, Li, Ting, Wan, Weiguo, Lu, Liangjing, Teng, Xiangyu, Morel, Laurence, Ye, Shuang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7583791/ https://www.ncbi.nlm.nih.gov/pubmed/33093216 http://dx.doi.org/10.1136/lupus-2020-000429 |
Ejemplares similares
-
Safety and efficacy of the SGLT2 inhibitor dapagliflozin in patients with systemic lupus erythematosus: a phase I/II trial
por: Wang, Huijing, et al.
Publicado: (2022) -
Lack of patient education is risk factor of disease flare in patients with systemic lupus erythematosus in China
por: Zhang, Le, et al.
Publicado: (2019) -
Risk factors of disease flares in a Chinese lupus cohort with low-grade disease activity
por: Sun, Fangfang, et al.
Publicado: (2022) -
Major infections in newly diagnosed systemic lupus erythematosus: an inception cohort study
por: Wang, Haiting, et al.
Publicado: (2022) -
D-mannose ameliorates autoimmune phenotypes in mouse models of lupus
por: Wang, Haiting, et al.
Publicado: (2021)